Literature DB >> 16008818

Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?

P G Ince1, G A Codd.   

Abstract

Recently published work provides evidence in support of the cycad hypothesis for Lytico--Bodig, the Guamanian amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC), based on a new understanding of Chamorro food practices, a cyanobacterial origin of beta-methylaminoalanine (BMAA) in cycad tissue, and a possible mechanism of biomagnification of this neurotoxic amino acid in the food chain. BMAA is one of two cycad chemicals with known neurotoxic properties (the other is cycasin, a proven developmental neurotoxin) among the many substances that exist in these highly poisonous plants, the seeds of which are used by Chamorros for food and medicine. The traditional diet includes the fruit bat, a species that feeds on cycad seed components and reportedly bioaccumulates BMAA. Plant and animal proteins provide a previously unrecognized reservoir for the slow release of this toxin. BMAA is reported in the brain tissue of Guam patients and early data suggest that some Northern American patients dying of Alzheimer's disease (AD) have detectable brain levels of BMAA. The possible role of cyanobacterial toxicity in sporadic neurodegenerative disease is therefore worthy of consideration. Recent neuropathology studies of ALS/PDC confirm understanding of this disorder as a 'tangle' disease, based on variable anatomical burden, and showing biochemical characteristics of 'AD-like' combined 3R and 4R tau species. This model mirrors the emerging view that other neurodegenerative disease spectra comprise clusters of related syndromes, owing to common molecular pathology, with variable anatomical distribution in the nervous system giving rise to different clinical phenotypes. Evidence for 'ubiquitin-only' inclusions in ALS/PDC is weak. Similarly, although there is evidence for alpha-synucleinopathy in ALS/PDC, the parkinsonian component of the disease is not caused by Lewy body disease. The spectrum of sporadic AD includes involvement of the substantia nigra and a high prevalence of 'incidental'alpha-synucleinopathy in sporadic AD is reported. Therefore the pathogenesis of Lytico-Bodig appears still to have most pertinence to the ongoing investigation of the pathogenesis of AD and other tauopathies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008818     DOI: 10.1111/j.1365-2990.2005.00686.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  13 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Environmental neurotoxin-induced progressive model of parkinsonism in rats.

Authors:  Wei-Bin Shen; Kimberly A McDowell; Aubrey A Siebert; Sarah M Clark; Natalie V Dugger; Kimberly M Valentino; H A Jinnah; Carole Sztalryd; Paul S Fishman; Christopher A Shaw; M Samir Jafri; Paul J Yarowsky
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

3.  Intravenous injection of l-BMAA induces a rat model with comprehensive characteristics of amyotrophic lateral sclerosis/Parkinson-dementia complex.

Authors:  Ke-Wei Tian; Hong Jiang; Bei-Bei Wang; Fan Zhang; Shu Han
Journal:  Toxicol Res (Camb)       Date:  2015-11-10       Impact factor: 3.524

4.  PARADOXICAL RESPONSES TO NEUROTOXIC STERYL GLYCOSIDES: INSIGHTS FROM A CELLULAR MODEL OF ALSPDC.

Authors:  Christopher A Shaw; Steven Pelech; Philip T T Ly
Journal:  Neurobiol Lipids       Date:  2009-01-15

5.  Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).

Authors:  Filiz Koç; Mehmet Balal; Turgay Demir; Z Nazan Alparslan; Yakup Sarica
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

6.  Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms.

Authors:  Doug Lobner; Peachy Mae T Piana; Abed K Salous; Robert W Peoples
Journal:  Neurobiol Dis       Date:  2006-11-13       Impact factor: 5.996

7.  Prominent human health impacts from several marine microbes: history, ecology, and public health implications.

Authors:  P K Bienfang; S V Defelice; E A Laws; L E Brand; R R Bidigare; S Christensen; H Trapido-Rosenthal; T K Hemscheidt; D J McGillicuddy; D M Anderson; H M Solo-Gabriele; A B Boehm; L C Backer
Journal:  Int J Microbiol       Date:  2010-10-11

Review 8.  The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.

Authors:  Sandra Anne Banack; Tracie A Caller; Elijah W Stommel
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546

Review 9.  Recreational and occupational field exposure to freshwater cyanobacteria--a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessment.

Authors:  Ian Stewart; Penelope M Webb; Philip J Schluter; Glen R Shaw
Journal:  Environ Health       Date:  2006-03-24       Impact factor: 5.984

10.  Production of the neurotoxin BMAA by a marine cyanobacterium.

Authors:  Sandra Anne Banack; Holly E Johnson; Ran Cheng; Paul Alan Cox
Journal:  Mar Drugs       Date:  2007-12-06       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.